Jazz Tops Q3 Earnings Sales Estimates, Raises 24 EPS View
FOLD Stock | USD 9.98 0.02 0.20% |
About 72% of Amicus Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Amicus Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Amicus Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Amicus Therapeutics stock news signals to limit their universe of possible portfolio assets.
Amicus |
JAZZ reports better-than-expected third-quarter results. After initiating a strategic pipeline prioritization program, the company raises its EPS guidance for 2024 by 30 cents.
Read at finance.yahoo.com
Amicus Therapeutics Current Investor Sentiment
Panic Vs Confidence
28
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Amicus Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Amicus Therapeutics.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentDisposing |
Amicus Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Amicus Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Amicus Therapeutics Historical Investor Sentiment
Investor biases related to Amicus Therapeutics' public news can be used to forecast risks associated with an investment in Amicus. The trend in average sentiment can be used to explain how an investor holding Amicus can time the market purely based on public headlines and social activities around Amicus Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amicus Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amicus Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Amicus Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Amicus Therapeutics.
Amicus Therapeutics Fundamental Analysis
We analyze Amicus Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amicus Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amicus Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Amicus Therapeutics is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Amicus Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amicus Therapeutics stock to make a market-neutral strategy. Peer analysis of Amicus Therapeutics could also be used in its relative valuation, which is a method of valuing Amicus Therapeutics by comparing valuation metrics with similar companies.
Peers
Amicus Therapeutics Related Equities
MLYS | Mineralys Therapeutics, | 5.64 | ||||
LEGN | Legend Biotech | 2.95 | ||||
DNLI | Denali Therapeutics | 2.52 | ||||
KURA | Kura Oncology | 1.45 | ||||
HRMY | Harmony Biosciences | 1.33 | ||||
BPMC | Blueprint Medicines | 1.29 | ||||
MREO | Mereo BioPharma | 0.55 | ||||
CRNX | Crinetics Pharmaceuticals | 0.33 | ||||
ARGX | Argenx NV | 0.25 | ||||
RARE | Ultragenyx | 0.06 | ||||
DAWN | Day One | 0.65 | ||||
AGIO | Agios Pharm | 0.88 | ||||
INBX | Inhibrx | 1.18 | ||||
BMRN | Biomarin Pharmaceutical | 1.50 | ||||
INCY | Incyte | 1.81 | ||||
CYTK | Cytokinetics | 2.37 | ||||
ARVN | Arvinas | 3.74 | ||||
DYN | Dyne Therapeutics | 4.34 | ||||
EWTX | Edgewise Therapeutics | 4.42 | ||||
RVMD | Revolution Medicines | 10.46 |
Complementary Tools for Amicus Stock analysis
When running Amicus Therapeutics' price analysis, check to measure Amicus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amicus Therapeutics is operating at the current time. Most of Amicus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Amicus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amicus Therapeutics' price. Additionally, you may evaluate how the addition of Amicus Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Stocks Directory Find actively traded stocks across global markets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |